Trade Gilead ^GILD

Eukles Asset Management Cuts Position in Gilead Sciences, Inc. $GILD

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio

Todd Asset Management LLC Increases Stake in Gilead Sciences, Inc. $GILD

May 2026's Top Stocks That Could Be Trading Below Estimated Fair Value - Simply Wall St News

Gilead Sciences, Inc. $GILD Shares Sold by Simplify Asset Management Inc. - Zolmax

Simplify Asset Management Inc. Lowers Stake in Gilead Sciences, Inc. $GILD

Legal & General Group Plc Acquires 107,014 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Zacks Research Expects Lower Earnings for Gilead Sciences

Maxim Upgrades Gilead Sciences (GILD) to 'Buy'

Gilead Sciences Highlights Trodelvy Lung Data, Long-Acting HIV Pipeline at RBC Conference

Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Recommendation of "Moderate Buy" by Brokerages

Gilead Sciences, Inc. $GILD Shares Sold by GPS Wealth Strategies Group LLC - Zolmax

LSV Asset Management Has $508.91 Million Position in Gilead Sciences, Inc. $GILD

Global Retirement Partners LLC Grows Position in Gilead Sciences, Inc. $GILD - Stock Observer

Experimental treatments could help US Ebola patient

GILD Receives FDA Approval for Hepcludex, First Treatment for Chronic HDV Infection

Gilead Sciences Gets FDA Green Light for Chronic HDV Drug | Morningstar

US FDA approves Gilead's drug for deadly liver infection - AOL

US FDA approves Gilead's drug for deadly liver infection - Yahoo News Canada

FDA Grants Accelerated Approval to Gilead's Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)

GILD: Gilead's Trodelvy Gains Positive Opinion for TNBC Treatment in Europe

Gilead Gets Positive Opinion From European Regulators on Breast-Cancer Treatment | Morningstar

Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors

Zacks Research Forecasts Weaker Earnings for Gilead Sciences

PNC Financial Services Group Inc. Buys 53,135 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

- ASCO Presentations on Trodelvy ® in First-line Metastatic

Gilead Sciences (GILD) Is Among The Best Extremely Profitable Stocks To Buy According To Wall Street Analysts

Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now

Gilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio

Hepatic Impairment Market Analysis Report 2026-2036 Featuring AbbVie, Astellas Pharma, Gilead Sciences, F. Hoffmann La Roche, and Takeda Pharmaceuticals

GILD Partners with WHO to Combat Visceral Leishmaniasis

Leonteq Securities AG Takes Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (GILD) Announces Issuance of Senior Notes in New Indenture Agreement

How Investors May Respond To Gilead Sciences (GILD) Multi‑Billion Laddered Bond Issuance And Capital Plan

GILD Maintains a $122 Price Target Following Healthcare Conference

Gilead Sciences (NASDAQ:GILD) Upgraded to Buy at Maxim Group

Morgan Stanley Reassesses Gilead Sciences (GILD) Outlook Following Quarterly Report

Gilead Sciences, Inc. $GILD Shares Sold by Mitsubishi UFJ Asset Management UK Ltd.

Banque Cantonale Vaudoise Has $8.71 Million Stock Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Banque Cantonale Vaudoise

Atle Fund Management AB Sells 27,373 Shares of Gilead Sciences, Inc. $GILD

Envestnet Portfolio Solutions Inc. Boosts Position in Gilead Sciences, Inc. $GILD - Daily Political

Atle Fund Management AB Has $6.24 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Cost-effectiveness of community interventions to promote awareness, testing and treatment of hepatitis B and C in migrant populations in Catalonia

5 Best Long Term Low Risk Stocks to Buy According to Hedge Funds

Attractive medium-term compounder with catalyst-rich profile, but with short-term volatility tied to investment phase

ProShare Advisors LLC Buys 623,752 Shares of Gilead Sciences, Inc. $GILD

Profund Advisors LLC Buys 15,824 Shares of Gilead Sciences, Inc. $GILD

HighTower Advisors LLC Lowers Stake in Gilead Sciences, Inc. $GILD - Zolmax

HighTower Advisors LLC Decreases Stake in Gilead Sciences, Inc. $GILD

RBC Capital Sticks to Its Hold Rating for aTyr Pharma (ATYR)

Optimising patient centred drug development to realise impact

Gilead Sciences (NASDAQ:GILD) Insider Sells $3,676,120.00 in Stock

Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion

45,461 Shares in Gilead Sciences, Inc. $GILD Purchased by North Dakota State Investment Board

Erste Group Bank Predicts Gilead Sciences FY2026 Earnings

Top Pharmaceutical Stocks To Keep An Eye On - May 17th - Stock Observer

Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline

Leuthold Group LLC Boosts Stake in Gilead Sciences, Inc. $GILD

L & S Advisors Inc Invests $5.09 Million in Gilead Sciences, Inc. $GILD

STF Management LP Sells 11,745 Shares of Gilead Sciences, Inc. $GILD

iA Global Asset Management Inc. Increases Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Canada Post Corp Registered Pension Plan

Abacus Wealth Partners LLC Buys Shares of 12,486 Gilead Sciences, Inc. $GILD

Bank Julius Baer & Co. Ltd Zurich Sells 4,174 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences, Inc. $GILD Shares Sold by STF Management LP - Daily Political

AlphaCore Capital LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences, Inc. $GILD Position Lessened by Canada Post Corp Registered Pension Plan - Daily Political

Abacus Wealth Partners LLC Makes New $1.53 Million Investment in Gilead Sciences, Inc. $GILD - Daily Political

Evaluating Gilead Sciences (GILD) Valuation After Q1 Beat Guidance Shift And New HIV Priority Review

Lawood & Co. Invests $633,000 in Gilead Sciences, Inc. $GILD - Zolmax

A Look At Gilead Sciences (GILD) Valuation After The Recent Share Price Pullback

Gilead Sciences, Inc. $GILD Shares Acquired by Commerzbank Aktiengesellschaft FI

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

Yield-Hungry Investors Bet on Credit as Government Debt Sours

Gilead Sciences (GILD) Prices $3B Senior Unsecured Notes Offering

Arbejdsmarkedets Tillaegspension Takes Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Conning Inc. - Daily Political

Company Website: https://www.gilead.com/ FOSTER CITY, Cali

Gilead Prices $3 Billion of Senior Unsecured Notes

Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons

Gilead Liver Data At EASL Tests Case For A Third Growth Pillar

PRMT5 inhibitors detailed in Gilead Sciences patent | BioWorld

Top Pharmaceutical Stocks To Watch Now - May 13th - Daily Political

Trek Financial LLC Purchases 13,041 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al - Stock Observer

Gilead Sciences Inc at Bank of America Global Healthcare Conference Transcript

Promising Medical Stocks Worth Watching - May 9th - Stock Observer

Money Concepts Capital Corp Sells 4,126 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Bailard Inc. Has $90.10 Million Stock Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences, Inc. (GILD) Outlook Cut Sharply on $11.5B IPR&D and Financing Costs

LA500 2026: Arie Belldegrun